InceptionR’s Syndax Pharmaceuticals SNDX Stock Holding History

InceptionR’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,747	Closed	-$226K	–	883
2025 Q4	$226K	Buy	+10,747	New	+$187K	0.06%	512

Other funds holding SNDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

InceptionR's SNDX Position: Q1 2026 in Review

InceptionR sold out of Syndax Pharmaceuticals (SNDX) in Q1 2026, closing a stake of 10,747 shares — an estimated $226K sold.

InceptionR first reported a position in SNDX in Q4 2025 and held it in 1 quarter. The position peaked at $226K in Q4 2025. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

InceptionR reported no remaining Syndax Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
InceptionR sold 10,747 Syndax Pharmaceuticals shares in Q1 2026, an estimated $226K.
InceptionR first reported a position in Syndax Pharmaceuticals in Q4 2025 and held it in 1 quarter.
InceptionR's Syndax Pharmaceuticals position peaked at $226K in Q4 2025.
246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on InceptionR's 13F filing for Q1 2026, filed 14 May 2026.